Matches in Wikidata for { <http://www.wikidata.org/entity/Q57257527> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q57257527 description "article scientifique publié en 2017" @default.
- Q57257527 description "article" @default.
- Q57257527 description "im September 2017 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57257527 description "wetenschappelijk artikel" @default.
- Q57257527 description "наукова стаття, опублікована у вересні 2017" @default.
- Q57257527 name "Profiting from Innovation through Cross-Border Market co-Creation and co-Opetition: The Case of Global Pharmaceuticals" @default.
- Q57257527 name "Profiting from Innovation through Cross-Border Market co-Creation and co-Opetition: The Case of Global Pharmaceuticals" @default.
- Q57257527 type Item @default.
- Q57257527 label "Profiting from Innovation through Cross-Border Market co-Creation and co-Opetition: The Case of Global Pharmaceuticals" @default.
- Q57257527 label "Profiting from Innovation through Cross-Border Market co-Creation and co-Opetition: The Case of Global Pharmaceuticals" @default.
- Q57257527 prefLabel "Profiting from Innovation through Cross-Border Market co-Creation and co-Opetition: The Case of Global Pharmaceuticals" @default.
- Q57257527 prefLabel "Profiting from Innovation through Cross-Border Market co-Creation and co-Opetition: The Case of Global Pharmaceuticals" @default.
- Q57257527 P1433 Q57257527-E3BF168C-6FD7-435B-BFC1-F398382C6BFA @default.
- Q57257527 P1476 Q57257527-2F2F24D1-BFED-4F95-87DB-4A12E212AE93 @default.
- Q57257527 P2093 Q57257527-1C5F1CF8-FB51-493B-8EFA-3D31D951FD85 @default.
- Q57257527 P2093 Q57257527-8B354FBE-5E59-487B-BDF0-E1CF10A0BBFE @default.
- Q57257527 P2093 Q57257527-AE738201-47E3-485F-9837-6FCFED492C65 @default.
- Q57257527 P2860 Q57257527-4576A88D-29B5-46F5-B3B2-C0A495A24C55 @default.
- Q57257527 P2860 Q57257527-6C474088-8BB1-4EB7-9EE8-FD22E5A720C4 @default.
- Q57257527 P2860 Q57257527-72865D9C-D685-409C-AF6D-7489676F6688 @default.
- Q57257527 P2860 Q57257527-7BB46D4E-0A4F-45D6-A026-20D96AD89580 @default.
- Q57257527 P2860 Q57257527-9135023E-CA1C-4C14-96B3-EB6AB2E65B63 @default.
- Q57257527 P31 Q57257527-DD97CCCD-5431-4D49-A1B0-81559B71B2AC @default.
- Q57257527 P356 Q57257527-297DC0F9-15A8-4FE5-9C24-59DCBF52A217 @default.
- Q57257527 P577 Q57257527-90491CA0-113E-4A4C-8A49-6FD78C84435C @default.
- Q57257527 P921 Q57257527-7A3231A7-8DC0-4F2D-8159-EE5FE577EF38 @default.
- Q57257527 P356 EMRE.12138 @default.
- Q57257527 P1433 Q5412794 @default.
- Q57257527 P1476 "Profiting from Innovation through Cross-Border Market co-Creation and co-Opetition: The Case of Global Pharmaceuticals" @default.
- Q57257527 P2093 "Andreas Panagopoulos" @default.
- Q57257527 P2093 "Christos N. Pitelis" @default.
- Q57257527 P2093 "Panos Desyllas" @default.
- Q57257527 P2860 Q29039428 @default.
- Q57257527 P2860 Q44563506 @default.
- Q57257527 P2860 Q46372464 @default.
- Q57257527 P2860 Q55891508 @default.
- Q57257527 P2860 Q56335941 @default.
- Q57257527 P31 Q13442814 @default.
- Q57257527 P356 "10.1111/EMRE.12138" @default.
- Q57257527 P577 "2017-09-18T00:00:00Z" @default.
- Q57257527 P921 Q615782 @default.